2008-09-01
Letter
Publication
Publication
International Journal of Gynecological Cancer , Volume 18 - Issue 5 p. 1152
Additional Metadata | |
---|---|
antineoplastic agent, area under the curve, body surface, carboplatin, chromium 51, clinical practice, creatinine, creatinine clearance, disease severity, dose response, drug blood level, drug clearance, drug formulation, edetic acid, gynecologic cancer, human, kidney function, letter, practice guideline, priority journal, prospective study, unspecified side effect | |
dx.doi.org/10.1111/j.1525-1438.2007.01119.x, hdl.handle.net/1765/14851 | |
International Journal of Gynecological Cancer | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
de Jong, F.A, Verweij, J, & Sparreboom, A. (2008). Letter. International Journal of Gynecological Cancer, 18(5). doi:10.1111/j.1525-1438.2007.01119.x
|